Report cover image

Global Oral Transmucosal Drugs Market Growth, Size, Trends Analysis - By Product Type, By Route of Administration, By Indication, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 01, 2025
Length 263 Pages
SKU # SPER20295382

Description

Oral Transmucosal Drugs Market Introduction and Overview

According to SPER market research, ‘Global Oral Transmucosal Drugs Market Size- By Product Type, By Route of Administration, By Indication, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Oral Transmucosal Drugs Market is predicted to reach 71.75 billion by 2034 with a CAGR of 6.94%.

Oral transmucosal drugs are medicines that are absorbed through the mouth’s mucous membranes, providing quick relief while bypassing first metabolism in the liver and gastrointestinal system. These medications are frequently used for disorders that require immediate relief, such as pain management, as well as for people who have difficulty swallowing pills. Tablets, films, liquid formulations, sprays, and other similar forms are the most common oral transmucosal medications.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered

By Product Type, By Route of Administration, By Indication, By Distribution Channel

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Aquestive Therapeutics, Inc, C.L.Pharm Co., Ltd, Cure Pharmaceutical, IntelGenx Technologies Corp, Jazz Pharmaceuticals, plc, NAL Pharma, Novartis AG, Pfizer Inc, Teva Pharmaceutical Industries Limited, ZIM Laboratories Limited.

Global Oral Transmucosal Drugs Market Segmentation:

By Product Type: Based on the Product Type, Global Oral Transmucosal Drugs Market is segmented as; Tablet, Film, Liquid & Spray.

By Route of Administration: Based on the Route of Administration, Global Oral Transmucosal Drugs Market is segmented as; Sublingual mucosa, Buccal mucosa, Other routes of administration.

By Indication:
Based on the Indication, Global Oral Transmucosal Drugs Market is segmented as; Opioid Dependence, Nausea & Vomiting, Erectile Dysfunction, Neurological Disorders.

By Distribution Channel: Based on the Distribution Channel, Global Oral Transmucosal Drugs Market is segmented as; Hospital pharmacies, Retail pharmacies, Online pharmacies.

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

263 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Oral Transmucosal Drugs Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Oral Transmucosal Drugs Market
7. Global Oral Transmucosal Drugs Market, By Product Type (USD Million) 2021-2034
7.1. Tablets
7.2. Films
7.3. Liquid & spray
7.4. Other product types
8. Global Oral Transmucosal Drugs Market, By Route of Administration (USD Million) 2021-2034
8.1. Sublingual mucosa
8.2. Buccal mucosa
8.3. Other routes of administration
9. Global Oral Transmucosal Drugs Market, By Indication (USD Million) 2021-2034
9.1. Opioid dependence
9.2. Nausea and vomiting
9.3. Erectile dysfunction
9.4. Neurological disorders
9.5. Other indications
10. Global Oral Transmucosal Drugs Market, By Distribution Channel (USD Million) 2021-2034
10.1. Hospital pharmacies
10.2. Retail pharmacies
10.3. Online pharmacies
11. Global Oral Transmucosal Drugs Market, (USD Million) 2021-2034
11.1. Global Oral Transmucosal Drugs Market Size and Market Share
12. Global Oral Transmucosal Drugs Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6.Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Aquestive Therapeutics, Inc
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. C.L.Pharm Co., Ltd
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Cure Pharmaceutical
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. IntelGenx Technologies Corp
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Jazz Pharmaceuticals, plc
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. NAL Pharma
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Novartis AG
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Pfizer Inc
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Teva Pharmaceutical Industries Limited
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. ZIM Laboratories Limited
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us